NOACs Use in AF or VTE (SUNSHINE Registry)

Sponsor
Henan Provincial People's Hospital
Study ID
NCT05378308
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Patients with Atrial Fibrillation (AF) or venous thromboembolism (VTE) — OTHER
    Patients with AF or VTE; OAC treatment patterns according to patient demographics, clinical factors, risk stratification, geographic regions, local NOAC medical insurance policy and NOACs availability

Study Details

The outcomes regiStry for non-vitamin k antagonist oral anticoagUlants treatmeNt in variouS tHrombotIc dIseases for better cliNical practicE (SUNSHINE) is a multicenter, prospective, observational non-interventional inpatient/outpatient disease registry to assess the utilization of Non-vitamin k antagonist oral anticoagulants (NOACs), and associated outcomes. The SUNSHINE registry will focus on the collection and analysis of observational data in medical records from hospital information system (HIS) to evaluate the outcomes related with these NOACs when applied in extensive patient populations outside of clinical research studies. The registry will also allow for mainly combining the atrial fibrillation (AF) and venous thromboembolism (VTE) databases. In brief, the SUNSHINE registry will provide important information on the outcomes of NOACs in routine practice and gather further information on its safety and effectiveness.

Key Dates

First listed
May 18, 2022
Start date
Jun 6, 2022
Status verified
May 2022
Primary completion
May 31, 2027
Completion
May 31, 2027

Study Design

Enrollment
5,000 participants (estimated)

Primary Outcome Measure

Profiles of patients with OACs [ Time Frame: During hospitalization ]

Central Contacts

Find similar trials

Nationwide
Atrial fibrillation trialsCardiology trialsHeart disease trials

Related Studies